These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16718522)

  • 1. Technical hurdles in a pilot clinical trial of combined B7-2 and GM-CSF immunogene therapy for glioblastomas and melanomas.
    Parney IF; Chang LJ; Farr-Jones MA; Hao C; Smylie M; Petruk KC
    J Neurooncol; 2006 May; 78(1):71-80. PubMed ID: 16718522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human autologous in vitro models of glioma immunogene therapy using B7-2, GM-CSF, and IL12.
    Parney IF; Farr-Jones MA; Kane K; Chang LJ; Petruk KC
    Can J Neurol Sci; 2002 Aug; 29(3):267-75. PubMed ID: 12195617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte-macrophage colony-stimulating factor and B7-2 combination immunogene therapy in an allogeneic Hu-PBL-SCID/beige mouse-human glioblastoma multiforme model.
    Parney IF; Petruk KC; Zhang C; Farr-Jones M; Sykes DB; Chang LJ
    Hum Gene Ther; 1997 Jun; 8(9):1073-85. PubMed ID: 9189765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I/IB study of immunization with autologous tumor cells transfected with the GM-CSF gene by particle-mediated transfer in patients with melanoma or sarcoma.
    Mahvi DM; Sondel PM; Yang NS; Albertini MR; Schiller JH; Hank J; Heiner J; Gan J; Swain W; Logrono R
    Hum Gene Ther; 1997 May; 8(7):875-91. PubMed ID: 9143914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase 1 clinical trial of irradiated autologous melanoma cells adenovirally transduced with human GM-CSF gene.
    Kusumoto M; Umeda S; Ikubo A; Aoki Y; Tawfik O; Oben R; Williamson S; Jewell W; Suzuki T
    Cancer Immunol Immunother; 2001 Sep; 50(7):373-81. PubMed ID: 11676397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenoviral-mediated transfer of human wild-type p53, GM-CSF and B7-1 genes results in growth suppression and autologous anti-tumor cytotoxicity of multiple myeloma cells in vitro.
    Ren SP; Wu CT; Huang WR; Lu ZZ; Jia XX; Wang L; Lao MF; Wang LS
    Cancer Immunol Immunother; 2006 Apr; 55(4):375-85. PubMed ID: 16001164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer.
    Simons JW; Jaffee EM; Weber CE; Levitsky HI; Nelson WG; Carducci MA; Lazenby AJ; Cohen LK; Finn CC; Clift SM; Hauda KM; Beck LA; Leiferman KM; Owens AH; Piantadosi S; Dranoff G; Mulligan RC; Pardoll DM; Marshall FF
    Cancer Res; 1997 Apr; 57(8):1537-46. PubMed ID: 9108457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human brain tumor cell culture characterization after immunostimulatory gene transfer.
    Parney IF; Farr-Jones MA; Koshal A; Chang LJ; Petruk KC
    Neurosurgery; 2002 May; 50(5):1094-102. PubMed ID: 11950413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of T-cell apoptosis in rats by genetically engineered glioma cells expressing granulocyte-macrophage colony-stimulating factor and B7.1.
    Tseng SH; Chen Y; Chang CJ; Tai KF; Lin SM; Hwang LH
    Clin Cancer Res; 2005 Feb; 11(4):1639-49. PubMed ID: 15746069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of gene transduction of granulocyte macrophage colony-stimulating factor in cancer vaccine using genetically modified dendritic cells.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Yamaue H
    Int J Oncol; 2007 Oct; 31(4):931-9. PubMed ID: 17786327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma.
    Soiffer R; Hodi FS; Haluska F; Jung K; Gillessen S; Singer S; Tanabe K; Duda R; Mentzer S; Jaklitsch M; Bueno R; Clift S; Hardy S; Neuberg D; Mulligan R; Webb I; Mihm M; Dranoff G
    J Clin Oncol; 2003 Sep; 21(17):3343-50. PubMed ID: 12947071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene immunotherapy in murine acute myeloid leukemia: granulocyte-macrophage colony-stimulating factor tumor cell vaccines elicit more potent antitumor immunity compared with B7 family and other cytokine vaccines.
    Dunussi-Joannopoulos K; Dranoff G; Weinstein HJ; Ferrara JL; Bierer BE; Croop JM
    Blood; 1998 Jan; 91(1):222-30. PubMed ID: 9414288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of murine melanoma growth by granulocyte-macrophage colony stimulating factor gene transfection is not haplotype specific.
    Botella R; Sarradet MD; Potter LE; Lawley M; Galloway TH; Ansel JC; Armstrong CA
    Melanoma Res; 1998 Jun; 8(3):245-54. PubMed ID: 9664146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus mediated transfer of p53, GM-CSF and B7-1 suppresses growth and enhances immunogenicity of glioma cells.
    Pan D; Wei X; Liu M; Feng S; Tian X; Feng X; Zhang X
    Neurol Res; 2010 Jun; 32(5):502-9. PubMed ID: 19589203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen-specific cancer immunotherapy using a GM-CSF secreting allogeneic tumor cell-based vaccine.
    Chang EY; Chen CH; Ji H; Wang TL; Hung K; Lee BP; Huang AY; Kurman RJ; Pardoll DM; Wu T
    Int J Cancer; 2000 Jun; 86(5):725-30. PubMed ID: 10797297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenetic therapy of human melanoma utilizing autologous tumor cells transduced to secrete granulocyte-macrophage colony-stimulating factor.
    Chang AE; Li Q; Bishop DK; Normolle DP; Redman BD; Nickoloff BJ
    Hum Gene Ther; 2000 Apr; 11(6):839-50. PubMed ID: 10779161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative antitumor effect of preventive versus therapeutic vaccines employing B16 melanoma cells genetically modified to express GM-CSF and B7.2 in a murine model.
    Miguel A; Herrero MJ; Sendra L; Botella R; Algás R; Sánchez M; Aliño SF
    Toxins (Basel); 2012 Oct; 4(11):1058-81. PubMed ID: 23202306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte-macrophage colony-stimulating factor gene-transduced tumor cells combined with tumor-derived gp96 inhibit tumor growth in mice.
    Kojima T; Yamazaki K; Tamura Y; Ogura S; Tani K; Konishi J; Shinagawa N; Kinoshita I; Hizawa N; Yamaguchi E; Dosaka-Akita H; Nishimura M
    Hum Gene Ther; 2003 May; 14(8):715-28. PubMed ID: 12804136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local and distant immunity induced by intralesional vaccination with an oncolytic herpes virus encoding GM-CSF in patients with stage IIIc and IV melanoma.
    Kaufman HL; Kim DW; DeRaffele G; Mitcham J; Coffin RS; Kim-Schulze S
    Ann Surg Oncol; 2010 Mar; 17(3):718-30. PubMed ID: 19915919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand.
    Mach N; Gillessen S; Wilson SB; Sheehan C; Mihm M; Dranoff G
    Cancer Res; 2000 Jun; 60(12):3239-46. PubMed ID: 10866317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.